Lose The Belly Fat And Save Your Brain From Shrinking

Lose The Belly Fat And Save Your Brain From Shrinking



The battle of the bulge is a losing proposition for many Americans. According to data derived from the most recent (2015–2016) National Health and Nutrition Examination Surveys (NHANES), the prevalence of obesity among U.S. adults was 39.8%.(1)

Visceral fat—the deeper belly fat that accumulates around the organs of the abdominal cavity, is linked to many health disorders that include heart disease, type 2 diabetes, high blood pressure (hypertension, and dementia. 

With the evidence mounting on the associations between obesity, heart disease (CVD), and type 2 diabetes (T2D), to an increased risk for Alzheimer’s disease, an increased awareness of these associations and how it is all connected, now appears regularly in many popular news feeds. (more…)

Polyphenols in the Protection Against Cardiovascular Disease and Dementia

Polyphenols in the Protection Against Cardiovascular Disease and Dementia

In a recently published study—NutriNet-Santé (10/2018)—that included the analysis of dietary records of 84,158 French adults that spanned between May 2009 and June 20017—  the study authors concluded found that “Higher intakes of polyphenols, especially anthocyanins and catechins (flavan-3-ols), were associated with a statistically significant decreased cardiovascular disease risk.”(1).

The polyphenol intake was primarily derived from coffee (49%), tea (23%), fruits (17%), vegetables (8%), and wine (5%). (more…)

Alzheimer’s Prevention Trials—The Future Looks Promising

Alzheimer’s Prevention Trials—The Future Looks Promising

While there is active research for more effective disease-modifying drugs* the lack of any significant breakthroughs in the treatment of the Alzheimer’s disease has propelled a paradigm shift away from focusing solely on a drug solution, to an inclusive prevention model that emphasizes risk reduction and prevention, which promises to attenuate the portentous global burden incurred by the disease.

Current prevalence estimates (2016) for late-onset Alzheimer’s disease (LOAD) in the United States (U.S.) is approximately 5.1 million.(1) By 2050 the projected prevalence of LOAD is expected to escalate to 13.8 million and a staggering 106.8 million worldwide.(2,3) Pharmacological treatments for LOAD such as cholinesterase inhibitors and NMDA receptor antagonists may slow its progression or attenuate specific molecular pathomechanisms associated with the disease process, but are not long term solutions or curative.
(more…)

MEMBER ACCESS: Blueberry Polyphenols Protect the Brain from the Degenerative Processes Associated with Brain Aging and Alzheimer’s Disease

MEMBER ACCESS: Blueberry Polyphenols Protect the Brain from the Degenerative Processes Associated with Brain Aging and Alzheimer’s Disease

The study of plant and fruit polyphenols, a rich source of dietary antioxidants, represents one of t...

Members Only

This is member access content and is available with a free Brainy member registration.

If you have already registered, please login below.

If you have not setup your free lifetime membership you can learn more and register for access along with my newsletter here.

 

MEMBER ACCESS: Mild Cognitive Impairment (MCI)—Telltale Signs That You May Be At Increased Risk for Dementia or Alzheimer’s Disease

MEMBER ACCESS: Mild Cognitive Impairment (MCI)—Telltale Signs That You May Be At Increased Risk for Dementia or Alzheimer’s Disease

By Ralph Sanchez, L.Ac.,CNS,D.Hom
Long before a diagnosis of dementia or Alzheimers disease (AD) is ...

Members Only

This is member access content and is available with a free Brainy member registration.

If you have already registered, please login below.

If you have not setup your free lifetime membership you can learn more and register for access along with my newsletter here.

 

Pin It on Pinterest